Skip to content
Home/Companies/Pharma/Aliri
Aliri

Aliri

Pharma·United States·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Aliri?

Aliri is an American Pharma company, currently owned by ARCHIMED since 2021.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
ARCHIMED
Investor
ARCHIMED
MED III · 2021 · Buyout

Key facts

HQUnited States
SectorPharma
Websitealiribio.com

More from MED III

Other portfolio companies in the same fund.

BioVendor Group
Active
MedTechCzech Republic· 2025
DermaPharm
DermaPharm
Active
HealthTechDenmark· 2025
Natus Sensory
Natus Sensory
Active
MedTechUS· 2022
PlasmidFactory
PlasmidFactory
Active
BiotechGermany· 2022
Title21 Health Solutions
Title21 Health Solutions
Active
HealthTechUS· 2022
Cardioline
Cardioline
Active
MedTechItaly· 2021

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Aliri?

Aliri is currently owned by ARCHIMED, through MED III, since 2021.

When did ARCHIMED acquire Aliri?

ARCHIMED acquired Aliri in 2021.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue